Benzinga's Top Downgrades

Analysts at Goldman Sachs downgraded Heartware International

from “neutral” to “sell.” The target price for Heartware International has been lowered from $94 to $73. Heartware's shares closed at $81.26 on Friday. Analysts at Deutsche Bank downgraded Microsoft

from “buy” to “hold.” The target price for Microsoft is set to $42. Microsoft's shares closed at $39.21 on Friday. Morgan Stanley downgraded Mindray Medical International

from “overweight” to “equal-weight.” The target price for Mindray Medical has been lowered from $44 to $37. Mindray Medical's shares closed at $33.08 on Friday. Analysts at Credit Suisse downgraded Enbridge

from “outperform” to “neutral.” Enbridge's shares closed at $46.60 on Friday.